TARS
Tarsus Pharmaceuticals Inc
75.70$
-0.4%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | – | – | – | -1,408.2% | – | – | – | |
| – | +3,600.0% | +159.5% | +225.0% | +4.2% | +169.8% | +39.7% | +48.2% | |
| – | +100.0% | +4,561.1% | +907.7% | +59.2% | +47.3% | +40.3% | +50.0% | |
| – | +4,766.7% | +806.2% | +278.0% | -6.9% | – | – | – | |
| – | +284.9% | +200.6% | -5.9% | -169.3% | – | +1,156.2% | +280.8% | |
| – | +2,400.0% | +160.6% | +28.5% | -13.7% | +987.4% | -71.5% | +529.2% | |
| – | +2,400.0% | +160.6% | +28.5% | +24,580.7% | – | -241.7% | -78.9% | |
| – | – | – | – | +23,028.7% | – | – | – | |
| – | +0.0% | +905.5% | +0.0% | -104.4% | – | +650.0% | -100.0% | |
| – | +1,567.9% | +121.7% | -100.0% | +447,457.1% | +38.5% | +18.8% | -7.3% | |
| – | +2,241.9% | +98.2% | -97.1% | -3,231.4% | – | -183.2% | – | |
| – | – | – | – | -1,666.6% | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.